Provided by Tiger Trade Technology Pte. Ltd.

SAB Biotherapeutics, Inc.

3.64
-0.1450-3.84%
Volume:545.70K
Turnover:2.02M
Market Cap:330.74M
PE:-2.34
High:3.76
Open:3.75
Low:3.61
Close:3.78
52wk High:5.15
52wk Low:1.85
Shares:90.99M
Float Shares:62.04M
Volume Ratio:1.66
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5562
EPS(LYR):-0.7944
ROE:-11.27%
ROA:-33.46%
PB:1.54
PE(LYR):-4.58

Loading ...

Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 21, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 25, 2024

Major Issues Report

Form 8-K - Current report